Use of FSH receptor ligands for diagnosis and therapy of cancer
AssigneesInserm (Institut National De La Sante Et De La Recherche Medicale), Mount Sinai School of Medicine
InventorsNicolae Ghinea, Aurelian Radu
Life of this patent
Estimating the term…
Abstract
The present invention relates to diagnostic imaging and in particular to the diagnostic imaging and therapy of cancer by means of compositions which specifically target the FSH Receptor expressed by tumor endothelial cells and circulating blood cells.
Claims13
A method for imaging vessels associated with a tumor in a patient, the method comprising administering a labeled Vascular Endothelial follicle-stimulating hormone (FSH) receptor (VE-FSHR) ligand to said patient and imaging said patient to detect the in vivo binding of said ligand to a VE-FSHR in vessels associated with the tumor in said patient.
Dependencies are inferred from the claim text.